UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017576
Receipt number R000020365
Scientific Title Randomized pilot study of optimal dose period for indisetron tablets for preventing chemotherapy-induced nausea and vomiting with mFOLFOX6: HGCSG0703
Date of disclosure of the study information 2015/05/14
Last modified on 2015/05/14 23:43:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized pilot study of optimal dose period for indisetron tablets for preventing chemotherapy-induced nausea and vomiting with mFOLFOX6: HGCSG0703

Acronym

Randomized pilot study of optimal dose period for indisetron tablets for preventing chemotherapy-induced nausea and vomiting with mFOLFOX6: HGCSG0703

Scientific Title

Randomized pilot study of optimal dose period for indisetron tablets for preventing chemotherapy-induced nausea and vomiting with mFOLFOX6: HGCSG0703

Scientific Title:Acronym

Randomized pilot study of optimal dose period for indisetron tablets for preventing chemotherapy-induced nausea and vomiting with mFOLFOX6: HGCSG0703

Region

Japan


Condition

Condition

colorectal cancer

Classification by specialty

Gastroenterology Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To explore the optimal dosing period for indisetron tablets for preventing chemotherapy-induced nausea and vomiting with mFOLFOX6

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

Complete protection from vomiting

Key secondary outcomes

Complete protection from nausea
No use of rescue therapy
Tolerability


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

3-day indisetron regimen

Interventions/Control_2

1-day indisetron regimen

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1. patients with advanced or metastatic colorectal cancer
2. scheduled to receive full dose of mFOLFOX6 as 1st line chemotherapy, with or without targeted agents
3. age 20-80 years old
4. ECOG performance status 0-2
5. written informed consent

Key exclusion criteria

1. had any known central nervous system malignancy
2. had any seizure disorder needing anticovulsants
3. had active gastrointestinal ulcers or obstruction
4. had any other organic cause of nausea or vomiting unrelated to chemotherapy
5. were scheduled to undergo radiotherapy
6. were pregnant or nursing women
7. had any history of drug hypersensitivity

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshito Komatsu

Organization

Hokkaido University Hospital

Division name

Cancer Center

Zip code


Address

14-5 Kita-ku, Sapporo, Hokkaido, 060-8648, JPN

TEL

81-11-706-5657

Email

ykomatsu@med.hokudai.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hiroshi Nakatsumi

Organization

Hokkaido University Hospital

Division name

Gastroenterology and Hepatology

Zip code


Address

14-5 Kita-ku, Sapporo, Hokkaido, 060-8648, JPN

TEL

81-11-706-5657

Homepage URL

http://www.hgcsg.com/

Email

tsumi1979@gmail.com


Sponsor or person

Institute

Hokkaido Gastrointestinal Cancer Study Group (HGCSG)

Institute

Department

Personal name



Funding Source

Organization

Hokkaido Gastrointestinal Cancer Study Group (HGCSG)

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

none

Name of secondary funder(s)

none


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北海道大学病院(北海道)、苫小牧日翔病院(北海道)、苫小牧市立病院(北海道)、札幌北楡病院(北海道)、岩見沢市立総合病院(北海道)、釧路労災病院(北海道)、北見赤十字病院(北海道)、北海道消化器科病院(北海道)


Other administrative information

Date of disclosure of the study information

2015 Year 05 Month 14 Day


Related information

URL releasing protocol

http://www.hgcsg.com/

Publication of results

Published


Result

URL related to results and publications

http://www.karger.com/Article/FullText/345920

Number of participants that the trial has enrolled


Results

Proportions of patients with complete protection from vomiting were 85.7% (95% confidence interval (CI), 63.7-97.0%) with the 3-day regimen, and 81.0% (95%CI, 58.1-94.6%) with the 1-day regimen. Proportions of patients with complete protection from nausea were 47.6% in each arm (95%CI, 25.7-70.2%). No rescue therapy rates were 66.7% (95%CI, 43.0-85.4%) vs. 57.1% (95%CI, 34.0-78.2%). No severe adverse events were observed in either arm.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2007 Year 12 Month 25 Day

Date of IRB


Anticipated trial start date

2008 Year 01 Month 09 Day

Last follow-up date

2009 Year 09 Month 04 Day

Date of closure to data entry

2009 Year 09 Month 04 Day

Date trial data considered complete

2009 Year 12 Month 31 Day

Date analysis concluded

2009 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2015 Year 05 Month 14 Day

Last modified on

2015 Year 05 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020365


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name